Follow us

Personal information protection policy
Terms of Use
Site Map
Career

Top Page
About Us
R&D
Investor Relations
Contact Us
[Link to Japanese page]
SNS

トップページ
Top Page
News Release
Release
China SFDA Approves F647／Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis

News Release

China SFDA Approves F647／Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis

China SFDA Approves F647／Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis

SAPA-President Forum
World Orphan Drug Congress

News Release

Information
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
Event Calendar
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
Release
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007

Top Page
About Us
R&D
Investor Relations
Contact Us [Link to Japanese page]

News Release
Privacy Policy
Terms of Use
Site Map
Career

© GNI Group Ltd. All Rights Reserved.